Skip to main content
. 2021 Sep 4;10:131–144. doi: 10.1016/j.bioactmat.2021.08.030

Scheme 1.

Scheme 1

Experimental design. Schematic illustration of the co-introduction of CAP and Cb-Vp as the exogenous irradiation-free photosynthetic bacteria-based platform for photodynamic cancer therapy with the continuous output of O2 (tumor hypoxia alleviation) and 1O2 (tumor therapy), achieving the enhanced photodynamic therapeutic effects and outcome.